301 related articles for article (PubMed ID: 23138183)
1. Abrogation of MLL-AF10 and CALM-AF10-mediated transformation through genetic inactivation or pharmacological inhibition of the H3K79 methyltransferase Dot1l.
Chen L; Deshpande AJ; Banka D; Bernt KM; Dias S; Buske C; Olhava EJ; Daigle SR; Richon VM; Pollock RM; Armstrong SA
Leukemia; 2013 Apr; 27(4):813-22. PubMed ID: 23138183
[TBL] [Abstract][Full Text] [Related]
2. Leukemic transformation by the MLL-AF6 fusion oncogene requires the H3K79 methyltransferase Dot1l.
Deshpande AJ; Chen L; Fazio M; Sinha AU; Bernt KM; Banka D; Dias S; Chang J; Olhava EJ; Daigle SR; Richon VM; Pollock RM; Armstrong SA
Blood; 2013 Mar; 121(13):2533-41. PubMed ID: 23361907
[TBL] [Abstract][Full Text] [Related]
3. Leukaemic transformation by CALM-AF10 involves upregulation of Hoxa5 by hDOT1L.
Okada Y; Jiang Q; Lemieux M; Jeannotte L; Su L; Zhang Y
Nat Cell Biol; 2006 Sep; 8(9):1017-24. PubMed ID: 16921363
[TBL] [Abstract][Full Text] [Related]
4. DOT1L, the H3K79 methyltransferase, is required for MLL-AF9-mediated leukemogenesis.
Nguyen AT; Taranova O; He J; Zhang Y
Blood; 2011 Jun; 117(25):6912-22. PubMed ID: 21521783
[TBL] [Abstract][Full Text] [Related]
5. CALM-AF10+ T-ALL expression profiles are characterized by overexpression of HOXA and BMI1 oncogenes.
Dik WA; Brahim W; Braun C; Asnafi V; Dastugue N; Bernard OA; van Dongen JJ; Langerak AW; Macintyre EA; Delabesse E
Leukemia; 2005 Nov; 19(11):1948-57. PubMed ID: 16107895
[TBL] [Abstract][Full Text] [Related]
6. A novel chromosomal inversion at 11q23 in infant acute myeloid leukemia fuses MLL to CALM, a gene that encodes a clathrin assembly protein.
Wechsler DS; Engstrom LD; Alexander BM; Motto DG; Roulston D
Genes Chromosomes Cancer; 2003 Jan; 36(1):26-36. PubMed ID: 12461747
[TBL] [Abstract][Full Text] [Related]
7. A CALM-derived nuclear export signal is essential for CALM-AF10-mediated leukemogenesis.
Conway AE; Scotland PB; Lavau CP; Wechsler DS
Blood; 2013 Jun; 121(23):4758-68. PubMed ID: 23487024
[TBL] [Abstract][Full Text] [Related]
8. MLL and CALM are fused to AF10 in morphologically distinct subsets of acute leukemia with translocation t(10;11): both rearrangements are associated with a poor prognosis.
Dreyling MH; Schrader K; Fonatsch C; Schlegelberger B; Haase D; Schoch C; Ludwig W; Löffler H; Büchner T; Wörmann B; Hiddemann W; Bohlander SK
Blood; 1998 Jun; 91(12):4662-7. PubMed ID: 9616163
[TBL] [Abstract][Full Text] [Related]
9. Identification and molecular characterization of CALM/AF10fusion products in T cell acute lymphoblastic leukemia and acute myeloid leukemia.
Carlson KM; Vignon C; Bohlander S; Martinez-Climent JA; Le Beau MM; Rowley JD
Leukemia; 2000 Jan; 14(1):100-4. PubMed ID: 10637483
[TBL] [Abstract][Full Text] [Related]
10. The lncRNA LAMP5-AS1 drives leukemia cell stemness by directly modulating DOT1L methyltransferase activity in MLL leukemia.
Wang WT; Chen TQ; Zeng ZC; Pan Q; Huang W; Han C; Fang K; Sun LY; Yang QQ; Wang D; Luo XQ; Sun YM; Chen YQ
J Hematol Oncol; 2020 Jun; 13(1):78. PubMed ID: 32552847
[TBL] [Abstract][Full Text] [Related]
11. Selective killing of mixed lineage leukemia cells by a potent small-molecule DOT1L inhibitor.
Daigle SR; Olhava EJ; Therkelsen CA; Majer CR; Sneeringer CJ; Song J; Johnston LD; Scott MP; Smith JJ; Xiao Y; Jin L; Kuntz KW; Chesworth R; Moyer MP; Bernt KM; Tseng JC; Kung AL; Armstrong SA; Copeland RA; Richon VM; Pollock RM
Cancer Cell; 2011 Jul; 20(1):53-65. PubMed ID: 21741596
[TBL] [Abstract][Full Text] [Related]
12. The leukemogenic CALM/AF10 fusion protein alters the subcellular localization of the lymphoid regulator Ikaros.
Greif PA; Tizazu B; Krause A; Kremmer E; Bohlander SK
Oncogene; 2008 May; 27(20):2886-96. PubMed ID: 18037964
[TBL] [Abstract][Full Text] [Related]
13. Complementary activities of DOT1L and Menin inhibitors in MLL-rearranged leukemia.
Dafflon C; Craig VJ; Méreau H; Gräsel J; Schacher Engstler B; Hoffman G; Nigsch F; Gaulis S; Barys L; Ito M; Aguadé-Gorgorió J; Bornhauser B; Bourquin JP; Proske A; Stork-Fux C; Murakami M; Sellers WR; Hofmann F; Schwaller J; Tiedt R
Leukemia; 2017 Jun; 31(6):1269-1277. PubMed ID: 27840424
[TBL] [Abstract][Full Text] [Related]
14. t(10;11)-acute leukemias with MLL-AF10 and MLL-ABI1 chimeric transcripts: specific expression patterns of ABI1 gene in leukemia and solid tumor cell lines.
Shibuya N; Taki T; Mugishima H; Chin M; Tsuchida M; Sako M; Kawa K; Ishii E; Miura I; Yanagisawa M; Hayashi Y
Genes Chromosomes Cancer; 2001 Sep; 32(1):1-10. PubMed ID: 11477655
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological inhibition of LSD1 for the treatment of MLL-rearranged leukemia.
Feng Z; Yao Y; Zhou C; Chen F; Wu F; Wei L; Liu W; Dong S; Redell M; Mo Q; Song Y
J Hematol Oncol; 2016 Mar; 9():24. PubMed ID: 26970896
[TBL] [Abstract][Full Text] [Related]
16. Global reduction of the epigenetic H3K79 methylation mark and increased chromosomal instability in CALM-AF10-positive leukemias.
Lin YH; Kakadia PM; Chen Y; Li YQ; Deshpande AJ; Buske C; Zhang KL; Zhang Y; Xu GL; Bohlander SK
Blood; 2009 Jul; 114(3):651-8. PubMed ID: 19443658
[TBL] [Abstract][Full Text] [Related]
17. A critical role for CRM1 in regulating HOXA gene transcription in CALM-AF10 leukemias.
Conway AE; Haldeman JM; Wechsler DS; Lavau CP
Leukemia; 2015 Feb; 29(2):423-32. PubMed ID: 25027513
[TBL] [Abstract][Full Text] [Related]
18. Tip60 activates Hoxa9 and Meis1 expression through acetylation of H2A.Z, promoting MLL-AF10 and MLL-ENL acute myeloid leukemia.
Yamagata K; Shino M; Aikawa Y; Fujita S; Kitabayashi I
Leukemia; 2021 Oct; 35(10):2840-2853. PubMed ID: 33967269
[TBL] [Abstract][Full Text] [Related]
19. Molecular analysis of the CALM/AF10 fusion: identical rearrangements in acute myeloid leukemia, acute lymphoblastic leukemia and malignant lymphoma patients.
Bohlander SK; Muschinsky V; Schrader K; Siebert R; Schlegelberger B; Harder L; Schemmel V; Fonatsch C; Ludwig WD; Hiddemann W; Dreyling MH
Leukemia; 2000 Jan; 14(1):93-9. PubMed ID: 10637482
[TBL] [Abstract][Full Text] [Related]
20. DOT1L inhibits SIRT1-mediated epigenetic silencing to maintain leukemic gene expression in MLL-rearranged leukemia.
Chen CW; Koche RP; Sinha AU; Deshpande AJ; Zhu N; Eng R; Doench JG; Xu H; Chu SH; Qi J; Wang X; Delaney C; Bernt KM; Root DE; Hahn WC; Bradner JE; Armstrong SA
Nat Med; 2015 Apr; 21(4):335-43. PubMed ID: 25822366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
